BDBM337379 4-[4-(4,6-Dimethylpyrimidin-5-yl)-3-methylphenoxy]-2,3-dihydrofuro[3,2-c]pyridin-3-ol (17)::US9745317, 17
SMILES: Cc1ncnc(C)c1-c1ccc(Oc2nccc3OCC(O)c23)cc1
InChI Key: InChIKey=ZBWWPSISVUMTPP-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D(1A) dopamine receptor (Homo sapiens (Human)) | BDBM337379 (4-[4-(4,6-Dimethylpyrimidin-5-yl)-3-methylphenoxy]...) | PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 28.9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pfizer Inc. US Patent | Assay Description D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determin... | US Patent US9745317 (2017) BindingDB Entry DOI: 10.7270/Q2W95CBQ | |||||||||||
More data for this Ligand-Target Pair |